Travere Therapeutics, Inc.
Develops therapies for rare kidney and metabolic diseases, with an FDA-approved treatment for IgA nephropathy.
TVTX | US
Overview
Corporate Details
- ISIN(s):
- US7612991064 (+1 more)
- LEI:
- Country:
- United States of America
- Address:
- 3611 VALLEY CENTRE DR, 92130 SAN DIEGO
- Website:
- https://travere.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Travere Therapeutics, Inc. is a biopharmaceutical company dedicated to identifying, developing, and delivering life-changing therapies for people with rare diseases. The company's primary focus is on advancing treatments for rare kidney and metabolic disorders, with a mission to establish new standards of care for underserved patient communities. Travere Therapeutics has a pipeline of potential therapies and has achieved full U.S. FDA approval for a non-immunosuppressive treatment for IgA nephropathy, a rare kidney disease. The company's approach is driven by science and collaboration with the rare disease community.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Travere Therapeutics, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Travere Therapeutics, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Travere Therapeutics, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
/other/Diamyd_Medical_AB_publ-logo.png){kind=logo}
